lobbying_activities: 3237784

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3237784	e86e2c46-950b-485d-b41e-eccb79174d92	Q3	NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD)	28264	NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)	2024	third_quarter	PHA	Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. H.R.7383/S.1214: RARE Act. Inflation Reduction Act Implementation. PRV Reauthorization. Lab-developed tests.	Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		60000	0	0	2024-10-15T10:45:24-04:00